胎儿及新生儿甲状腺功能障碍
本文综述胎儿及新生儿期甲状腺功能障碍的诊治,涵盖原发性及中枢性先天性甲状腺功能减退症、新生儿Graves病、甲状腺激素作用障碍等。强调新生儿筛查对原发性先天性甲状腺功能减退症的早期诊断价值,以及母体促甲状腺素受体抗体(TRAbs)经胎盘传递导致胎儿及新生儿自身免疫性甲状腺疾病的风险与处理。
要点
- 原发性先天性甲状腺功能减退症经新生儿筛查诊断,早期治疗可预防不可逆神经发育迟缓。
- 新生儿Graves病由母体促甲状腺素受体抗体(TRAbs)经胎盘传递所致,仅高刺激活性TRAbs者发病。
- 母体抗甲状腺药物可经胎盘治疗胎儿甲亢,但也可能导致胎儿及新生儿暂时性甲减。
核心结论
- 胎儿及新生儿甲状腺功能障碍包括持续性及暂时性多种疾病,早期诊断和治疗是优化患儿预后的关键。
研究设计与样本
- 本文为综述,聚焦胎儿及新生儿期甲状腺功能障碍的诊断与管理,并包含一例胎儿及新生儿自身免疫性甲状腺功能亢进症病例描述。
主要发现
- 原发性先天性甲状腺功能减退症通过新生儿筛查诊断,发达国家已实施40年,早期治疗可预防不可逆神经发育迟缓。
- 中枢性先天性甲状腺功能减退症较罕见,多与多种垂体激素缺乏相关。
- 新生儿Graves病由母体促甲状腺素受体抗体(TRAbs)经胎盘传递引起,仅高刺激活性TRAbs者发生甲亢。
- 以阻断性促甲状腺素受体抗体为主者可致暂时性甲减,随后可能发生新生儿甲亢,取决于抗体平衡。
- 母体抗甲状腺药物可经胎盘治疗胎儿甲亢,但也可能导致胎儿及新生儿暂时性甲减。
临床怎么用
- 应推广新生儿筛查以早期诊断原发性先天性甲状腺功能减退症并及时治疗。
- 对有水痘或现症Graves病母亲的胎儿及新生儿应监测TRAbs及甲状腺功能。
- 母体使用抗甲状腺药物时需警惕胎儿及新生儿暂时性甲减。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Fetal and neonatal dysfunctions include rare serious disorders involving abnormal thyroid function during the second half of gestation, which may persist throughout life, as for most congenital thyroid disorders, or be transient, resolving in the first few weeks of life, as in autoimmune hyperthyroidism or hypothyroidism and some cases of congenital hypothyroidism (CH) with the thyroid gland in situ. Primary CH is diagnosed by neonatal screening, which has been implemented for 40 years in developed countries and should be introduced worldwide, as early treatment prevents irreversible neurodevelopmental delay. Central CH is a rarer entity occurring mostly in association with multiple pituitary hormone deficiencies. Other rare disorders impair the action of thyroid hormones. Neonatal Graves' disease (GD) results from the passage of thyrotropin receptor antibodies (TRAbs) across the placenta, from mother to fetus. It may affect the fetuses and neonates of mothers with a history of current or past GD, but hyperthyroidism develops only in those with high levels of stimulatory TRAb activity. The presence of antibodies predominantly blocking thyroid-stimulating hormone receptors may result in transient hypothyroidism, possibly followed by neonatal hyperthyroidism, depending on the balance between the antibodies present. Antithyroid drugs taken by the mother cross the placenta, treating potential fetal hyperthyroidism, but they may also cause transient fetal and neonatal hypothyroidism. Early diagnosis and treatment are key to optimizing the child's prognosis. This review focuses on the diagnosis and management of these patients during the fetal and neonatal periods. It includes the description of a case of fetal and neonatal autoimmune hyperthyroidism.
引用
- Léger J, Delcour C, Carel JC, et al. Fetal and Neonatal Thyroid Dysfunction. J Clin Endocrinol Metab. 2022. PMID: 34636892. doi:10.1210/clinem/dgab747
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。